RELAPSING MULTIPLE SCLEROSIS (RMS)
Clinical trials for RELAPSING MULTIPLE SCLEROSIS (RMS) explained in plain language.
Never miss a new study
Get alerted when new RELAPSING MULTIPLE SCLEROSIS (RMS) trials appear
Sign up with your email to follow new studies for RELAPSING MULTIPLE SCLEROSIS (RMS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
MS drug gets new dosing test in major trial
Disease control OngoingThis study is testing whether a new, less frequent maintenance dosing schedule for the MS drug ofatumumab works as well as the current approved schedule. It involves 196 adults with relapsing forms of MS. The main goal is to see if the new dosing provides similar drug levels in t…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS (RMS)
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major MS drug trial enters final Long-Term safety phase
Disease control OngoingThis study is checking the long-term safety and effectiveness of the drug ublituximab for people with relapsing multiple sclerosis (RMS). It is open to 1100 people who have already completed one of the earlier, shorter studies of this drug. The main goal is to see how well the dr…
Matched conditions: RELAPSING MULTIPLE SCLEROSIS (RMS)
Phase: PHASE3 • Sponsor: TG Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC